US Chamber of Commerce poll of 10 District shows voters opposed to current health care reform proposal

17 March 2010

With US President Barack Obama running out of time to get the stalled health care reform back on track by the Easter congressional recess which starts March 26, there is disturbing news from the US Chamber of Commerce, which has released public opinion polls in 10 key congressional districts - all of which showed voters oppose current health care legislation being discussed in Congress, with substantial majorities saying it will raise the cost of their health care.

Polling showed voters in the selected districts are more likely to support their representative if he or she opposes the bill - even in districts where that vote would represent a switch from their vote last fall. The polls were conducted March 8-11 by Ayres, McHenry & Associates to gauge support for health legislation currently being proposed.

"There should be absolutely no question in anyone's mind how Americans view this health care bill," said Bruce Josten, executive vice president of Government Affairs at the US Chamber of Commerce. "This legislation is among the most unpopular proposals in recent memory and Members of Congress would be well advised to listen to their constituents' concerns," he added.

Poll overview and summary

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical